AGL 40.00 Decreased By ▼ -0.16 (-0.4%)
AIRLINK 129.53 Decreased By ▼ -2.20 (-1.67%)
BOP 6.68 Decreased By ▼ -0.01 (-0.15%)
CNERGY 4.63 Increased By ▲ 0.16 (3.58%)
DCL 8.94 Increased By ▲ 0.12 (1.36%)
DFML 41.69 Increased By ▲ 1.08 (2.66%)
DGKC 83.77 Decreased By ▼ -0.31 (-0.37%)
FCCL 32.77 Increased By ▲ 0.43 (1.33%)
FFBL 75.47 Increased By ▲ 6.86 (10%)
FFL 11.47 Increased By ▲ 0.12 (1.06%)
HUBC 110.55 Decreased By ▼ -1.21 (-1.08%)
HUMNL 14.56 Increased By ▲ 0.25 (1.75%)
KEL 5.39 Increased By ▲ 0.17 (3.26%)
KOSM 8.40 Decreased By ▼ -0.58 (-6.46%)
MLCF 39.79 Increased By ▲ 0.36 (0.91%)
NBP 60.29 No Change ▼ 0.00 (0%)
OGDC 199.66 Increased By ▲ 4.72 (2.42%)
PAEL 26.65 Decreased By ▼ -0.04 (-0.15%)
PIBTL 7.66 Increased By ▲ 0.18 (2.41%)
PPL 157.92 Increased By ▲ 2.15 (1.38%)
PRL 26.73 Increased By ▲ 0.05 (0.19%)
PTC 18.46 Increased By ▲ 0.16 (0.87%)
SEARL 82.44 Decreased By ▼ -0.58 (-0.7%)
TELE 8.31 Increased By ▲ 0.08 (0.97%)
TOMCL 34.51 Decreased By ▼ -0.04 (-0.12%)
TPLP 9.06 Increased By ▲ 0.25 (2.84%)
TREET 17.47 Increased By ▲ 0.77 (4.61%)
TRG 61.32 Decreased By ▼ -1.13 (-1.81%)
UNITY 27.43 Decreased By ▼ -0.01 (-0.04%)
WTL 1.38 Increased By ▲ 0.10 (7.81%)
BR100 10,407 Increased By 220 (2.16%)
BR30 31,713 Increased By 377.1 (1.2%)
KSE100 97,328 Increased By 1781.9 (1.86%)
KSE30 30,192 Increased By 614.4 (2.08%)

LAHORE: Pakistan Pharmaceutical Manufacturers Association (PPMA) has urged the government to update existing drug laws in line with the recommendations of the relevant stakeholders.

“There is a need of updating obsolete drug laws conforming to the global best practices, as it are in the larger interest of the patients and under stress pharma industry,” former Chairman PPMA Mian Khalid Misbah-ur-Rehman said while talking to a select group of media men.

He claimed that the multinationals (MNCs) were fast leaving the country due to excessive and unjustified regulations. “At present, only four MNCs are actively investing in the country. Patients are the ultimate sufferers, as the situation is going from bad to worse with every passing day and new therapies will become rare in times to come if immediate action is not taken,” Khalid Misbah said.

He requested government to intervene immediately for saving the local pharma industry in the larger interests of the country and the health sector. Referring to the existing laws, he said that the world has moved forward but Pakistan was still sticking to decades old regulations. He appreciated the federal government’s step of deregulating prices of non-essential drugs, saying this will provide much needed oxygen for survival of pharma industry and attract investment.

He further said that to fully realize the huge potential of earning much-needed foreign exchange through exports by Pharma sector it was critical to provide a conducive environment. “Drugs export of India is more than $28 billion annually. It is due to supportive environment there for FDI”, he said, adding: “There was a dire need to bring the pharma sector regulations up to the mark of neighboring countries as well as global best practices and make Pakistan an attractive market for investment with its population of over 240 million and generate pharma exports of US $ 3 billion within few years.”

He urged the government to amend existing drug laws and ensure timely revision of essential drugs prices to improve medicines availability, attract FDI and provide impetus for MNCs to stay in Pakistan to allow latest therapies to reach our country.

Copyright Business Recorder, 2024

Comments

Comments are closed.